Justin Briggs

VP Corporate Development

2024 - Current

Board Member

2023 - 2024

Zafrens is a company developing a massively parallel drug discovery platform.

Operating Partner

2024

Partner

2022 - 2024

Prime Movers Lab invests in breakthrough scientific startups founded by the world's prime movers – the inventors who transform billions of lives across energy, transportation, infrastructure, manufacturing, human augmentation, and agriculture. PML is actively investing out of Fund 3, an early stage fund, and has $1.2B under management. We offer Prime Movers comprehensive resources and integrated coaching to support the transformation of world-class technical experts into extraordinary executives. Our team has developed in-depth academic scientific research, commercialized novel intellectual property, scaled significant enterprises, and mentored renowned scientists on their entrepreneurial journey.

Venture Partner

2022 - 2022

Board Member

2023

LyGenesis is a clinical-stage startup pioneering the use of lymph nodes as living bioreactors to transform transplant medicine and expand the field of cell therapy for millions of patients.

Board Member

2023

Iridia is storing the world of data in physical form using nature's building block, DNA.

Board Member

2023

Morphoceuticals is developing therapeutics modulating the “bio-electrome” to regrow human limbs, repair injuries, and treat rare congenital diseases and malformations based on the research of Drs. Michael Levin and David Kaplan.

Venture Partner

2022

Board Member

2023 - 2024

Gilgamesh is a clinical-stage company developing safer, more beneficial molecules at the forefront of psychedelic medicine.

Board Member

2023 - 2024

Board Observer

2023 - 2024

Dimension inx manufactures the substrates for life for use as tissue therapeutics, including 3D printed bone grafts, soft tissue replacements, and injectable bioscaffolds.

Board Member

2022 - 2024